PLUR:NASDAQ
Pluri Inc
၂.၄၁ US$
arrow_upward
+၃.၈၈%(+၀.၀၉၀) 1D
ဇွန် ၁, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLUR...
Open
၂.၃၅ US$
High
၂.၅၀ US$
Low
၂.၃၀ US$
Mkt. cap
၂.၆၀ ကုဋေ
Avg. vol.
၁.၁၅ သောင်း
Volume
၄.၉၇ သောင်း
52-wk high
၅.၉၆ US$
52-wk low
၂.၂၂ US$
EPS
-၂.၈၉ US$
Beta
၀.၇၅
Shares outstanding
၁.၀၈ ကုဋေ
No. of employees
၁၃၅
Open
၂.၃၅ US$
High
၂.၅၀ US$
Low
၂.၃၀ US$
Mkt. cap
၂.၆၀ ကုဋေ
Avg. vol.
၁.၁၅ သောင်း
Volume
၄.၉၇ သောင်း
52-wk high
၅.၉၆ US$
52-wk low
၂.၂၂ US$
EPS
-၂.၈၉ US$
Beta
၀.၇၅
Shares outstanding
၁.၀၈ ကုဋေ
No. of employees
၁၃၅
News stories
From sources across the web
TipRanks
·
ပြီးခဲ့သည့် ၅ နာရီ
Pluri in Good-Faith Talks on EIB Loan Resolution
Investing.com
·
ပြီးခဲ့သည့် ၆ နာရီ
Pluri Inc. and European Investment Bank continue loan discussions, no enforcement action expected before July
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ ရက်
Pluri Inc. (PLUR): One of the Premier Lab-Grown Meat Stocks to Invest In
Profile
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. Wikipedia
About Pluri Inc
CEOYaky Yanay
Employees၁၃၅
Founded၂၀၀၁ မေ ၁၁
Headquartersဟိုင်ဖ, Haifa District, အစ္စရေး
Sector-
Websitepluri-biotech.com
AI content may include mistakes. Learn more